| abstract |
(57) [Summary]nPreparation of at least one pharmaceutical composition, especially a dermatological composition, or a cosmetic composition for the treatment of a disease associated with excessive release and / or synthesis of substance P, as a substance P antagonist, Disclosed is the use of β-adrenergic agonists. Topical, cosmetic or pharmaceutical compositions containing at least one β-adrenergic agonist, and for controlling pain resulting from excessive release and / or synthesis of substance P, or of cosmetic compositions A cosmetic treatment method for reducing irritation is disclosed. |